Skip to content

Ultramarathons and Impact of Phased Electromagnetic Field Therapy (PEMF)

The Pulmonary Consequences of Participating in the UTMB and Hong Kong 100 Ultramarathons and Impact of Phased Electromagnetic Field Therapy (PEMF)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03333135
Enrollment
72
Registered
2017-11-06
Start date
2016-12-12
Completion date
2021-06-15
Last updated
2022-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Ultramarathons, Electromagnetic field therapy, Endurance, Exercise, Environmental conditions

Brief summary

This research is being done to better understand the pulmonary consequences of completing an ultra marathon at altitude and a sea level city.

Detailed description

Subjects will be asked to undertake three (3) sets of assessments at prescribed time intervals: Baseline (at 72-24h prior to each event), immediately post (within 2h of race completion) and during recovery (within 24-48h of race completion). Each assessment will consist of 1)lung function tests; 2) a saliva and blood sample; 3) a lung and cardiac ultrasound. Subjects will be recruited from a range of age groups and fitness levels, before being divided into a sham or therapy group. Groups will use Pulsed Electromagnetic Field (PEMF) therapy or related sham before the event and during recovery.

Interventions

PEMF Therapy based on Biological Electromagnetic (BEM) microbial wave technology provides micro-magnetic emissions to the center of the palm (Laogong acupoint). While participating in the study, the subjects will undertake 2 sessions of therapy every day (1 session in the morning and evening). Each session will last for 16-min (8-min for left and 8-min for right hand).

PROCEDUREPulsed Electromagnetic Field Sham therapy

PEMF therapy will be administered however it will not produce micro-magnetic emissions. The therapy will be used on the center of the palm (Laogong acupoint) of each hand. While participating in the study, the subjects will undertake 2 sessions of therapy every day (1 session in the morning and evening). Each session will last for 16-min (8-min for left and 8-min for right hand).

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

Study team and participants will not know if they have received the PEMF therapy or the sham

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

Healthy endurance trained individuals participating in the Ultra Trail du Mont Blanc (UTMB) and/or Hong Kong 100 ultramarathons

Exclusion criteria

\> 65 years age

Design outcomes

Primary

MeasureTime frameDescription
Change in lung fluid assessed through diffusion capacity of the lungs for carbon monoxide and nitric oxidebaseline, within 2 hours of race completion, 24-48 hours post raceSubjects will take a maximal breath of a test gas mixture, hold that inhalation for 4 seconds and then exhale and the exhaled gas will be analyze to determine the change in gas concentrations between what was inhaled and exhaled. Comparison will be made between the change over time in this ability of gas to move from the lungs to the blood stream.
Change in right ventricle end diastolic area (EDA)baseline, within 2 hours of race completion, 24-48 hours post raceCardiac ultrasound (Philips CX50) will be performed to determine left and right ventricular morphology and function. Ultrasound will be performed in accordance with the recommendations of the American Society of Echocardiography guidelines (ASE). Imaging of the ventricles and the diameter during relaxation (diastole) will be captured and evaluated. Normal value for right ventricle EDA indexed to body surface area ranges between 5-12.6 cm\^2/m\^2 for males and 4.5-11.5 cm\^2/m\^2 for females .
Change in tricuspid annular plane systolic excursion (TAPSE)baseline, within 2 hours of race completion, 24-48 hours post raceAnother ultrasound metric that will be evaluated is tricuspid annular plane systolic excursion (TAPSE) which is used a parameter of global RV function which describes apex-to-base shortening. Normal value for TAPSE is above 16 mm.
Change in ratio between early mitral inflow velocity and mitral annular early diastolic velocity (E/e')baseline, within 2 hours of race completion, 24-48 hours post raceAnother ultrasound metric that will be evaluated is early mitral inflow velocity and mitral annular early diastolic velocity (E/e') which is used to evaluate the diastolic or relaxation function of the left ventricle. Normal value for E/e' is \<6.
Change in the ratio of peak velocity flow in early diastole (the E wave) to peak velocity flow in late diastole caused by atrial contraction (the A wave)baseline, within 2 hours of race completion, 24-48 hours post raceAnother ultrasound metric that will be evaluated is he ratio of peak velocity flow in early diastole (the E wave) to peak velocity flow in late diastole caused by atrial contraction (the A wave) (E/A) which is used to evaluate the diastolic filling of the left ventricle. Normal value for E/A is between 0.8 and 2.
Change in lung fluid assessed through ultrasound incidence of comet tailsbaseline, within 2 hours of race completion, 24-48 hours post raceUltrasound will be used to image 28 windows covering the 2nd through the 5th intercostal/rib space on the right and left sides of the chest. The number of comet tails observed over these 28 locations will be documented and the change in this number over the course of the study will be evaluated.

Secondary

MeasureTime frameDescription
Change in exhaled nitric oxidebaseline, within 2 hours of race completion, 24-48 hours post raceThe amount of nitric oxide in ones exhaled air will be measured by a handheld device. Levels under 25 parts per billion are normal, more than 35 parts per billion would be a sign of airway inflammation.
Change in hemoglobinbaseline, within 2 hours of race completion, 24-48 hours post raceA blood sample will be taken and analyzed to determine the amount of red blood cells and and hemoglobin in the blood. For males normal range for hemoglobin is 13.5-17.5 grams per deciliter and for females normal range for hemoglobin is 12.0-15.5 grams per deciliter. Low values means anemia is present and higher levels is a normal response to altitude.
Change in hematocritbaseline, within 2 hours of race completion, 24-48 hours post raceA blood sample will be taken and analyzed to determine the amount of red blood cells and and hemoglobin in the blood. For males normal range for hematocrit is 38.8-50% and for females normal range for hematocrit is 34.9-44.5% Low values means anemia is present and higher levels is a normal response to altitude.
Change in cardiac troponin Ibaseline, within 2 hours of race completion, 24-48 hours post raceTo determine if signs of cardiac damage, as its presence in the blood is a potential sign of damage to the heart muscle
Change in B-type natriuretic peptidebaseline, within 2 hours of race completion, 24-48 hours post raceTo determine if signs of cardiac damage, as its presence in the blood is a potential sign of damage to the heart muscle
Change in cortisolbaseline, within 2 hours of race completion, 24-48 hours post raceSaliva levels of cortisol will be measured as a metric of stress. Cortisol levels increase when you body is under stress.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026